Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-01 Sale | 2024-02-02 9:25 pm | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 11,819 | $3.843 | $45,420 | 303,489 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Option Award | 2024-02-02 9:25 pm | N/A 2034-01-30 | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 132,800 | $0 | 303,489 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 9:25 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 33,334 | $0 | 303,489 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:26 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 240,000 | $0 | 240,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 5:15 pm | N/A 2032-01-30 | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:51 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 117,300 | $0 | 117,300 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:04 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 82,508 | $0 | 82,508 (Indirect) | View |
Ownership | 2020-10-29 8:50 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 0 | $0 | 472,508 (Indirect) | View |